| 注册
首页|期刊导航|医学信息|苯那普利联合缬沙坦治疗糖尿病肾病的临床观察

苯那普利联合缬沙坦治疗糖尿病肾病的临床观察

佘健

医学信息Issue(30):35-36,2.
医学信息Issue(30):35-36,2.

苯那普利联合缬沙坦治疗糖尿病肾病的临床观察

Clinical Observation of Benazepril Combined with Valsartan in the Treatment of Diabetic Nephropathy

佘健1

作者信息

  • 1. 常德职业技术学院附属第一医院,湖南 常德 415000
  • 折叠

摘要

Abstract

Objective To study the benzene that captopril and valsartan the clinical ef ect of combined therapy for diabetic nephropathy. Methods 74 patients with diabetic nephropathy were randomly divided into two groups, one group 39 cases, control group 35 cases, observation group with benzene that captopril combined valsartan treatment, control group treated with benzene only the split, compared two groups of patients after treatment for 20 weeks 24 h urine protein and blood glucose, blood pressure, serum creatinine levels. Results Two groups of patients before and after treatment the blood sugar and blood pressure were significantly decreased, but there was no statistical y significant dif erence comparing the two groups after treatment, ( > 0.05);Observation group of patients after treatment of the 24 h urine protein and serum creatinine levels were significantly lower than before treatment ( < 0.05), and observation group decreased more obviously, the two groups after treatment was significant dif erence ( < 0.05). Conclusion Benzene that captopril combined valsartan than use benzene that captopril treatment of patients with diabetic nephropathy can ef ectively reduce serum creatinine and level of proteinuria, curative ef ect is bet er, worthy of promotion of use.

关键词

苯那普利/缬沙坦/糖尿病肾病

Key words

Benzene that split/Valsartan/Diabetic nephropathy

引用本文复制引用

佘健..苯那普利联合缬沙坦治疗糖尿病肾病的临床观察[J].医学信息,2014,(30):35-36,2.

医学信息

1006-1959

访问量4
|
下载量0
段落导航相关论文